Northwestern Mutual Wealth Management’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.78K | Hold |
255
| – | – | ﹤0.01% | 3038 |
|
|
2025
Q1 | $4.59K | Hold |
255
| – | – | ﹤0.01% | 2973 |
|
|
2024
Q4 | $4.29K | Hold |
255
| – | – | ﹤0.01% | 2989 |
|
|
2024
Q3 | $4.13K | Hold |
255
| – | – | ﹤0.01% | 2950 |
|
|
2024
Q2 | $2.1K | Hold |
255
| – | – | ﹤0.01% | 3089 |
|
|
2024
Q1 | $3.77K | Hold |
255
| – | – | ﹤0.01% | 2916 |
|
|
2023
Q4 | $3.7K | Hold |
255
| – | – | ﹤0.01% | 2947 |
|
|
2023
Q3 | $2.75K | Hold |
255
| – | – | ﹤0.01% | 2901 |
|
|
2023
Q2 | $3.29K | Hold |
255
| – | – | ﹤0.01% | 2888 |
|
|
2023
Q1 | $3.37K | Hold |
255
| – | – | ﹤0.01% | 2852 |
|
|
2022
Q4 | $3.83K | Hold |
255
| – | – | ﹤0.01% | 2797 |
|
|
2022
Q3 | $3K | Hold |
255
| – | – | ﹤0.01% | 2813 |
|
|
2022
Q2 | $3K | Hold |
255
| – | – | ﹤0.01% | 2857 |
|
|
2022
Q1 | $8K | Hold |
255
| – | – | ﹤0.01% | 2609 |
|
|
2021
Q4 | $7K | Hold |
255
| – | – | ﹤0.01% | 2687 |
|
|
2021
Q3 | $9K | Hold |
255
| – | – | ﹤0.01% | 2507 |
|
|
2021
Q2 | $11K | Hold |
255
| – | – | ﹤0.01% | 2400 |
|
|
2021
Q1 | $9K | Hold |
255
| – | – | ﹤0.01% | 2316 |
|
|
2020
Q4 | $9K | Hold |
255
| – | – | ﹤0.01% | 2228 |
|
|
2020
Q3 | $6K | Hold |
255
| – | – | ﹤0.01% | 2138 |
|
|
2020
Q2 | $5K | Hold |
255
| – | – | ﹤0.01% | 2075 |
|
|
2020
Q1 | $4K | Hold |
255
| – | – | ﹤0.01% | 2124 |
|
|
2019
Q4 | $5K | Hold |
255
| – | – | ﹤0.01% | 2081 |
|
|
2019
Q3 | $5K | Hold |
255
| – | – | ﹤0.01% | 2108 |
|
|
2019
Q2 | $7K | Hold |
255
| – | – | ﹤0.01% | 2057 |
|
|
2019
Q1 | $7K | Buy |
+255
| New | +$7K | ﹤0.01% | 2059 |
|